Amenorrhea historical perspective: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 16: Line 16:
* In 1885, Maury Deas, a British [[physician]], suggested [[Permanganate]] of [[Potash]] as a treatment option for [[psychosis]] associated amenorrhea.<ref name="pmid20751231">{{cite journal |vauthors=Deas PM |title=Note on the Use of Permanganate of Potash in Cases of Insanity Associated with Amenorrhoea |journal=Br Med J |volume=1 |issue=1268 |pages=778–9 |year=1885 |pmid=20751231 |pmc=2256047 |doi= |url=}}</ref>
* In 1885, Maury Deas, a British [[physician]], suggested [[Permanganate]] of [[Potash]] as a treatment option for [[psychosis]] associated amenorrhea.<ref name="pmid20751231">{{cite journal |vauthors=Deas PM |title=Note on the Use of Permanganate of Potash in Cases of Insanity Associated with Amenorrhoea |journal=Br Med J |volume=1 |issue=1268 |pages=778–9 |year=1885 |pmid=20751231 |pmc=2256047 |doi= |url=}}</ref>
* In 1894, Jollye, a British [[physician]], described a girl with secondary amenorrhea along with some symptoms reflecting [[brain]] mass lesion.<ref name="pmid20754906">{{cite journal |vauthors=Jollye FW |title=A Case of Amenorrhoea with Brain Symptoms |journal=Br Med J |volume=1 |issue=1747 |pages=1354–5 |year=1894 |pmid=20754906 |pmc=2404280 |doi= |url=}}</ref>
* In 1894, Jollye, a British [[physician]], described a girl with secondary amenorrhea along with some symptoms reflecting [[brain]] mass lesion.<ref name="pmid20754906">{{cite journal |vauthors=Jollye FW |title=A Case of Amenorrhoea with Brain Symptoms |journal=Br Med J |volume=1 |issue=1747 |pages=1354–5 |year=1894 |pmid=20754906 |pmc=2404280 |doi= |url=}}</ref>
* In 1910, Crowe, a Canadian [[physician]], was the first researcher mentioned the [[pituitary gland]] as a regulator of [[gonads]]' [[stem cell]]. '''Crowe SJ, Cushing H and Homans J (1910) Experimental hypophysectomy. Bull Johns Hopkins Hosp 21,127–167'''
* In 1910, Crowe, a Canadian [[physician]], was the first researcher mentioned the [[pituitary gland]] as a regulator of [[gonads]]' [[stem cell]].<ref>{{cite book | last = Crowe | first = SJ | title = Experimental hypophysectomy (Bulletin of the Johns Hopkins Hospital) | publisher = Johns Hopkins Press | location = Johns Hopkins Hospital | year = 1910 | ASIN = B00088F464 }}</ref>
* In 1912, Bernhard Aschner, an Austrian [[endocrinologist]], found that the gonad control by [[pituitary gland]] is already controlled by another superior center in the [[brain]]. He suggested [[hypophysis]], [[pituitary stalk]], and centres superior to the [[medulla oblongata]] as the controlling systems. Their dysfunction lead to [[hypopituitarism]] and also [[hypogonadism]].<ref name="Aschner1912">{{cite journal|last1=Aschner|first1=Bernhard|title=Ueber die Beziehungen zwischen Hypophysis und Genitale|journal=Archiv für Gynaekologie|volume=97|issue=2|year=1912|pages=200–228|issn=0003-9128|doi=10.1007/BF01726121}}</ref>  
* In 1912, Bernhard Aschner, an Austrian [[endocrinologist]], found that the gonad control by [[pituitary gland]] is already controlled by another superior center in the [[brain]]. He suggested [[hypophysis]], [[pituitary stalk]], and centres superior to the [[medulla oblongata]] as the controlling systems. Their dysfunction lead to [[hypopituitarism]] and also [[hypogonadism]].<ref name="Aschner1912">{{cite journal|last1=Aschner|first1=Bernhard|title=Ueber die Beziehungen zwischen Hypophysis und Genitale|journal=Archiv für Gynaekologie|volume=97|issue=2|year=1912|pages=200–228|issn=0003-9128|doi=10.1007/BF01726121}}</ref>  
* In 1926, Philip Smith, an American [[endocrinologist]], experienced and approved that implanting animals' [[pituitary glands]] into other animals (mice, cats, and rabbits) leads to initiate their [[puberty]] process, enlarging their [[gonads]].<ref name="Smith1926">{{cite journal|last1=Smith|first1=P. E.|title=Hastening Development of Female Genital System by Daily Homoplastic Pituitary Transplants.|journal=Experimental Biology and Medicine|volume=24|issue=2|year=1926|pages=131–132|issn=1535-3702|doi=10.3181/00379727-24-3260}}</ref>
* In 1926, Philip Smith, an American [[endocrinologist]], experienced and approved that implanting animals' [[pituitary glands]] into other animals (mice, cats, and rabbits) leads to initiate their [[puberty]] process, enlarging their [[gonads]].<ref name="Smith1926">{{cite journal|last1=Smith|first1=P. E.|title=Hastening Development of Female Genital System by Daily Homoplastic Pituitary Transplants.|journal=Experimental Biology and Medicine|volume=24|issue=2|year=1926|pages=131–132|issn=1535-3702|doi=10.3181/00379727-24-3260}}</ref>
* In 1926, Bernhard Zondek, a Israeli [[gynecologist]], did the same experience, injecting adult humans' or cows' [[pituitary glands]] to some immature animals and witnessing the rapid rush of their [[puberty]] process. '''Zondek B (1926) Ueber die Funktion des Ovariums. Zeitschr Geburtsh Gynäkol 90,327.'''
* In 1926, Bernhard Zondek, a Israeli [[gynecologist]], did the same experience, injecting adult humans' or cows' [[pituitary glands]] to some immature animals and witnessing the rapid rush of their [[puberty]] process.<ref>{{cite journal|last1=Zondek|first1=Bernhard|title=Ueber die Funktion des Ovariums.|journal=Zeitschr Geburtsh Gynäkol|volume=90|year=1926|pages=327}}</ref>
* In 1929, Bernhard Zondek, a Israeli [[gynecologist]], identified that [[pituitary gland]] secrets two major [[hormones]], that are completely controlling the sexual life and therefore maintaining the species. He named them "'''''prolan A'''''" and "'''''prolan B'''''", comes after the Latin word "'''''prole'''''" which means "'''''descendant'''''".<ref name="Zondek1929">{{cite journal|last1=Zondek|first1=Bernhard|title=Weitere Untersuchungen zur Darstellung, Biologie und Klinik des Hypophysenvorderlappen-Hormons (Prolan)|journal=Klinische Wochenschrift|volume=8|issue=4|year=1929|pages=157–159|issn=0023-2173|doi=10.1007/BF01748589}}</ref>
* In 1929, Bernhard Zondek, a Israeli [[gynecologist]], identified that [[pituitary gland]] secrets two major [[hormones]], that are completely controlling the sexual life and therefore maintaining the species. He named them "'''''prolan A'''''" and "'''''prolan B'''''", comes after the Latin word "'''''prole'''''" which means "'''''descendant'''''".<ref name="Zondek1929">{{cite journal|last1=Zondek|first1=Bernhard|title=Weitere Untersuchungen zur Darstellung, Biologie und Klinik des Hypophysenvorderlappen-Hormons (Prolan)|journal=Klinische Wochenschrift|volume=8|issue=4|year=1929|pages=157–159|issn=0023-2173|doi=10.1007/BF01748589}}</ref>
* In 1930, Philip Smith, an American [[endocrinologist]], suggested that excision of [[pituitary gland]] in immature animals can lead to failure of sexual maturation; while, can lead to [[gonadal]] [[atrophy]], regression of [[sexual characteristics]], and [[infertility]] in mature animals.<ref name="SteelmanPohley1953">{{cite journal|last1=Steelman|first1=Sanford L.|last2=Pohley|first2=Florence M.|title=ASSAY OF THE FOLLICLE STIMULATING HORMONE BASED ON THE AUGMENTATION WITH HUMAN CHORIONIC GONADOTROPIN|journal=Endocrinology|volume=53|issue=6|year=1953|pages=604–616|issn=0013-7227|doi=10.1210/endo-53-6-604}}</ref>
* In 1930, Philip Smith, an American [[endocrinologist]], suggested that excision of [[pituitary gland]] in immature animals can lead to failure of sexual maturation; while, can lead to [[gonadal]] [[atrophy]], regression of [[sexual characteristics]], and [[infertility]] in mature animals.<ref name="SteelmanPohley1953">{{cite journal|last1=Steelman|first1=Sanford L.|last2=Pohley|first2=Florence M.|title=ASSAY OF THE FOLLICLE STIMULATING HORMONE BASED ON THE AUGMENTATION WITH HUMAN CHORIONIC GONADOTROPIN|journal=Endocrinology|volume=53|issue=6|year=1953|pages=604–616|issn=0013-7227|doi=10.1210/endo-53-6-604}}</ref>
* In 1930, Bernhard Zondek, a Israeli [[gynecologist]], found prolan A responsible for follicular growth stimulation and prolan B responsible for [[ovulation]] induction and [[corpus luteum]] formation. Zondek revealed that prolan A and B together induced the "'''''fuliculin'''''" hormone from [[gonads]], while prolan B alone induced both fuliculin and "'''''lutein'''''" [[hormones]].<ref name="Zondek1930">{{cite journal|last1=Zondek|first1=Bernhard|title=über die Hormone des Hypophysenvorderlappens|journal=Klinische Wochenschrift|volume=9|issue=6|year=1930|pages=245–248|issn=0023-2173|doi=10.1007/BF01765181}}</ref>
* In 1930, Bernhard Zondek, a Israeli [[gynecologist]], found prolan A responsible for follicular growth stimulation and prolan B responsible for [[ovulation]] induction and [[corpus luteum]] formation. Zondek revealed that prolan A and B together induced the "'''''fuliculin'''''" hormone from [[gonads]], while prolan B alone induced both fuliculin and "'''''lutein'''''" [[hormones]].<ref name="Zondek1930">{{cite journal|last1=Zondek|first1=Bernhard|title=über die Hormone des Hypophysenvorderlappens|journal=Klinische Wochenschrift|volume=9|issue=6|year=1930|pages=245–248|issn=0023-2173|doi=10.1007/BF01765181}}</ref>
* In 1931, Fevold, an American zoologist, named fuliculin and lutein as [[Follicle stimulating hormone|follicle stimulating factor]] and [[Luteinizing hormone|luteinizing factor]], respectively. '''Fevold, H. L., Hisaw, F. L., & Leonard, S. L. (1931). The gonad stimulating and the luteinizing hormones of the anterior lobe of the hypophesis. ''American Journal of Physiology--Legacy Content'', ''97''(2), 291-301.'''
* In 1931, Fevold, an American zoologist, named fuliculin and lutein as [[Follicle stimulating hormone|follicle stimulating factor]] and [[Luteinizing hormone|luteinizing factor]], respectively.<ref>{{cite journal|last1=Fevold|first1=HL|last2=Hisaw|first2=FL|last3=Leonard|first3=SL|title=The gonad stimulating and the luteinizing hormones of the anterior lobe of the hypophesis.|journal=American Journal of Physiology--Legacy Content|volume=97|issue=2|year=1931|pages=291–301|issn=0002-9513|doi=}}</ref>


== Landmark Events in the Development of Treatment Strategies ==
== Landmark Events in the Development of Treatment Strategies ==

Revision as of 20:47, 19 September 2017

Amenorrhea Microchapters

Home

Patient Information

Primary amenorrhea
Secondary amenorrhea

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Amenorrhea from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Amenorrhea historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Amenorrhea historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Amenorrhea historical perspective

CDC on Amenorrhea historical perspective

Amenorrhea historical perspective in the news

Blogs on Amenorrhea historical perspective

Directions to Hospitals Treating Amenorrhea

Risk calculators and risk factors for Amenorrhea historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Eiman Ghaffarpasand, M.D. [2]

Overview

The Egyptian ancient belief honored menstrual blood as a life-giving nature. The Mesopotamian mother goddess, named Ninhursag, believed to create mankind from loam and her "blood of life". The first descriptions about disturbances in menstrual cycle are found in Papyrus Ebres [named after the Egyptologist Georg M. Ebers (1837-1898)], from New Kingdom period (1450-1550 B.C.E). They described the patients as a "women who suffers from the side of her pubic region as an irregularity of her menstruation". In 1907, British Medical Journal, released an article about different types of treatments (mostly herbal and conservative) for amenorrhea. In 1911, some researchers evaluate the therapeutic methods presented 4 years ago and make some suggestions to manage amenorrhea better. The term amenorrhea is derived from Greek language [a = negative, men = month, rhoia = flow], means lack of menstruation cycle in a woman.

Historical Perspective

  • The Egyptian ancient belief honored menstrual blood as a life-giving nature. The Mesopotamian mother goddess, named Ninhursag, believed to create mankind from loam and her "blood of life".[1]
  • The first descriptions about disturbances in menstrual cycle are found in Papyrus Ebres [named after the Egyptologist Georg M. Ebers (1837-1898)], from New Kingdom period (1450-1550 B.C.E). They described the patients as a "women who suffers from the side of her pubic region as an irregularity of her menstruation".[2][3]
  • In Papyrus Edwin Smith [named for an American antiques dealer (1822-1906)], from 2900 B.C.E, first definition of amenorrhea presented as "woman suffering in her abdomen, so that the menstrual discharge can not leave her". There are also herbal treatments suggestions for this condition in the Papyrus.[4]
  • The term amenorrhea is derived from Greek language [a = negative, men = month, rhoia = flow]. The opposite is the normal menstrual period.
  • Historically, the term amenorrhea has often been used as a euphemism for "unwanted pregnancy" and many folk treatments for this condition were in fact abortifacients.
  • In 1855, William Brinton, a British physician, presented a woman with secondary amenorrhea caused by severe cachexia due to chronic peptic ulcer disease.[5]
  • In 1885, Maury Deas, a British physician, suggested Permanganate of Potash as a treatment option for psychosis associated amenorrhea.[6]
  • In 1894, Jollye, a British physician, described a girl with secondary amenorrhea along with some symptoms reflecting brain mass lesion.[7]
  • In 1910, Crowe, a Canadian physician, was the first researcher mentioned the pituitary gland as a regulator of gonads' stem cell.[8]
  • In 1912, Bernhard Aschner, an Austrian endocrinologist, found that the gonad control by pituitary gland is already controlled by another superior center in the brain. He suggested hypophysis, pituitary stalk, and centres superior to the medulla oblongata as the controlling systems. Their dysfunction lead to hypopituitarism and also hypogonadism.[9]
  • In 1926, Philip Smith, an American endocrinologist, experienced and approved that implanting animals' pituitary glands into other animals (mice, cats, and rabbits) leads to initiate their puberty process, enlarging their gonads.[10]
  • In 1926, Bernhard Zondek, a Israeli gynecologist, did the same experience, injecting adult humans' or cows' pituitary glands to some immature animals and witnessing the rapid rush of their puberty process.[11]
  • In 1929, Bernhard Zondek, a Israeli gynecologist, identified that pituitary gland secrets two major hormones, that are completely controlling the sexual life and therefore maintaining the species. He named them "prolan A" and "prolan B", comes after the Latin word "prole" which means "descendant".[12]
  • In 1930, Philip Smith, an American endocrinologist, suggested that excision of pituitary gland in immature animals can lead to failure of sexual maturation; while, can lead to gonadal atrophy, regression of sexual characteristics, and infertility in mature animals.[13]
  • In 1930, Bernhard Zondek, a Israeli gynecologist, found prolan A responsible for follicular growth stimulation and prolan B responsible for ovulation induction and corpus luteum formation. Zondek revealed that prolan A and B together induced the "fuliculin" hormone from gonads, while prolan B alone induced both fuliculin and "lutein" hormones.[14]
  • In 1931, Fevold, an American zoologist, named fuliculin and lutein as follicle stimulating factor and luteinizing factor, respectively.[15]

Landmark Events in the Development of Treatment Strategies

  • In 1907, British Medical Journal, released an article about different types of treatments (mostly herbal and conservative) for amenorrhea.[16]
  • In 1911, some researchers evaluate the therapeutic methods presented 4 years ago and make some suggestions to manage amenorrhea better.[17]

References

  1. "Menstruation in ancient Egypt, by Petra Habiger, at the Museum of Menstruation and Women's Health".
  2. Sigerist, Henry (1951). A history of medicine. New York: Oxford. ISBN 9780195001020.
  3. "Reorganized text". JAMA Otolaryngol Head Neck Surg. 141 (5): 428. 2015. doi:10.1001/jamaoto.2015.0540. PMID 25996397.
  4. Breasted, James (1930). The Edwin Smith surgical papyrus, published in facsimile and hieroglyphic transliteration with translation and commentary in two volumes. Chicago, Ill: University of Chicago, Oriental Institute. ISBN 0-918986-73-7.
  5. Brinton W (1856). "ROYAL FREE HOSPITAL. ULCER OF THE STOMACH, COMPLICATED WITH AMENORRHOEA, TREATED SUCCESSFULLY". Assoc Med J. 4 (158): 22–4. PMC 2439376. PMID 20741224.
  6. Deas PM (1885). "Note on the Use of Permanganate of Potash in Cases of Insanity Associated with Amenorrhoea". Br Med J. 1 (1268): 778–9. PMC 2256047. PMID 20751231.
  7. Jollye FW (1894). "A Case of Amenorrhoea with Brain Symptoms". Br Med J. 1 (1747): 1354–5. PMC 2404280. PMID 20754906.
  8. Crowe, SJ (1910). Experimental hypophysectomy (Bulletin of the Johns Hopkins Hospital). Johns Hopkins Hospital: Johns Hopkins Press. ASIN B00088F464.
  9. Aschner, Bernhard (1912). "Ueber die Beziehungen zwischen Hypophysis und Genitale". Archiv für Gynaekologie. 97 (2): 200–228. doi:10.1007/BF01726121. ISSN 0003-9128.
  10. Smith, P. E. (1926). "Hastening Development of Female Genital System by Daily Homoplastic Pituitary Transplants". Experimental Biology and Medicine. 24 (2): 131–132. doi:10.3181/00379727-24-3260. ISSN 1535-3702.
  11. Zondek, Bernhard (1926). "Ueber die Funktion des Ovariums". Zeitschr Geburtsh Gynäkol. 90: 327.
  12. Zondek, Bernhard (1929). "Weitere Untersuchungen zur Darstellung, Biologie und Klinik des Hypophysenvorderlappen-Hormons (Prolan)". Klinische Wochenschrift. 8 (4): 157–159. doi:10.1007/BF01748589. ISSN 0023-2173.
  13. Steelman, Sanford L.; Pohley, Florence M. (1953). "ASSAY OF THE FOLLICLE STIMULATING HORMONE BASED ON THE AUGMENTATION WITH HUMAN CHORIONIC GONADOTROPIN". Endocrinology. 53 (6): 604–616. doi:10.1210/endo-53-6-604. ISSN 0013-7227.
  14. Zondek, Bernhard (1930). "über die Hormone des Hypophysenvorderlappens". Klinische Wochenschrift. 9 (6): 245–248. doi:10.1007/BF01765181. ISSN 0023-2173.
  15. Fevold, HL; Hisaw, FL; Leonard, SL (1931). "The gonad stimulating and the luteinizing hormones of the anterior lobe of the hypophesis". American Journal of Physiology--Legacy Content. 97 (2): 291–301. ISSN 0002-9513.
  16. "The Composition Of Certain Secret Remedies. VIII. "Female Medicines" on JSTOR".
  17. "THE COMPOSITION OF CERTAIN SECRET REMEDIES : PREPARATIONS FOR AMENORRHOEA AND OTHER WOMEN'S COMPLAINTS". Br Med J. 2 (2635): 32–7. 1911. PMC 2331498. PMID 20765710.


Template:WH Template:WS